title: Increased risk for gestational diabetes mellitus associated with insulin receptor and insulin-like growth factor II restriction fragment length polymorphisms.
abstract: Gestational diabetes mellitus (GDM) is defined as glucose intolerance with onset or first recognition during pregnancy. We have examined restriction fragment length polymorphisms (RFLPs) near "candidate diabetogenic genes" as one approach to identify molecular markers for GDM genes. Genotypes for insulin hypervariable region (HVR), insulin-like growth factor II (IGF2), insulin receptor (INSR), and glucose transporter (GLUT1) RFLPs were studied in 96 GDM and 164 control subjects, matched to GDM for race, age, and gravidity. Logistic regression analysis was used to explore the relationship between genotypes at these candidate gene loci and GDM, while adjusting for the effects of potential confounding variables. Among black subjects, the INSR allele 1 (P = 0.001) and interactions between INSR allele 1 with body mass index (BMI) (P = 0.002) and history of DM in subject's mother (P = 0.004) contributed significantly to GDM risk. Among Caucasian subjects, a similar relationship between the INSR allele 1 (P = 0.007) and INSR allele 1-BMI interactions (P = 0.011) on GDM risk were observed. In Caucasians, an additional significant risk factor was determined by an INSR allele 1-IGF2 allele 2 interaction (P = 0.018). No risk factors were identified in Hispanic subjects. These data continue to support the hypothesis that GDM is a heterogeneous disorder with respect to phenotypic and genotypic features. Furthermore, our data suggest that risk for GDM in black and Caucasian subjects is not due to obesity perse but to interactions between obesity and INSR alleles. In Caucasian women, INSR and IGF2 alleles interact to confer additional risk for GDM. Thus genes underlying susceptibility to GDM in some women may be similar to genes conferring risk to NIDDM, while in others novel genes may contribute to GDM risk.
authors.affiliation: Department of Obstetrics and Gynecology, University of Chicago, IL 60637.
authors.forename: C
authors.initials: C
authors.lastname: Ober
authors.forename: K S
authors.initials: KS
authors.lastname: Xiang
authors.forename: R A
authors.initials: RA
authors.lastname: Thisted
authors.forename: K A
authors.initials: KA
authors.lastname: Indovina
authors.forename: C J
authors.initials: CJ
authors.lastname: Wason
authors.forename: S
authors.initials: S
authors.lastname: Dooley
mesh_terms: D002874:Chromosome Mapping; D015342:DNA Probes; D003922:Diabetes Mellitus, Type 1 / Q000235:genetics*; D003924:Diabetes Mellitus, Type 2 / Q000235:genetics*; D005006:Ethnicity; D005260:Female; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D007335:Insulin-Like Growth Factor II / Q000235:genetics*; D008957:Models, Genetic; D009004:Monosaccharide Transport Proteins / Q000235:genetics; D012150:Polymorphism, Restriction Fragment Length; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000235:genetics*; D011972:Receptor, Insulin / Q000235:genetics*; D012307:Risk Factors; D013002:Somatomedins / Q000235:genetics*
chemical_list: D015342:DNA Probes; D009004:Monosaccharide Transport Proteins; D013002:Somatomedins; D007335:Insulin-Like Growth Factor II; D011972:Receptor, Insulin